Drug Manufacturer Most Volatile: KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Zogenix (NASDAQ:ZGNX), Rigel Pharmaceuticals (NASDAQ:RIGL), GW Pharmaceuticals (NASDAQ:GWPH)

Technology Stocks News 4

KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) presented at the 26th Annual ROTH Conference on Wednesday, March 12, 2014 in Laguna Niguel, Californi 8:00 – 8:30 AM. Pacific Time KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) stock performance was -5.03% in last session and finished the day at $3.02. Traded volume was 205,759.00million shares in the last session and the average volume of the stock remained 355.36K shares. KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) insider ownership is 39.05%.

Zogenix began shipping Zohydro to pharmacies last week. Shares of Zogenix Inc. (NASDAQ:ZGNX), the maker of Zohydro, plunged more than 20 percent after the announcement. Zogenix, Inc. (NASDAQ:ZGNX) dropped -3.54 percent to $3.54 Friday on volume of 5.45million shares. The intra-day range of the stock was $3.29 to $3.58. Zogenix, Inc. (NASDAQ:ZGNX) has a market capitalization of $493.97million.

After a positive last week, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a clinical stage drug development company, started its latest week on a positive note as well. Its latest earnings report and the research results for R118 has spiked the rally in the stock. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)’s stock on Mar 14, 2014 reported a increase of 15.46% to the closing price of $4.63. Its fifty two week range is $2.31-$7.61. The total market capitalization recorded $405.24million. The overall volume in the last trading session was 1.93million shares. In its share capital, RIGL has 87.43 million outstanding shares.

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), the developer of cannabis-based painkillers, continued its yo-yo performance this week, as its shares joined the biggest small-cap risers. On Friday, shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) dropped -7.71% to close the day at $74.69. Company return on investment (ROI) is -12.50% and its monthly performance is recorded as 17.77%. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) quarterly revenue growth is 144.40%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone